المؤلفون: Valverde Morales, Claudia Maria

Thesis Advisors: Romagosa Pérez-Portabella, Cleofé, Carles Galceran, Joan, Vargas Blasco, Víctor

المصدر: TDX (Tesis Doctorals en Xarxa)

مصطلحات موضوعية: Prescreening molecular, Molecular prscreening, Sarcoma, Plataformes genòmiques, Genomic platforms, Plataformas genómicas, Ciències de la Salut

وصف الملف: application/pdf

URL الوصول: http://hdl.handle.net/10803/691591

المؤلفون: Agulnik, Mark, Chalmers, Anna, ITALIANO, ANTOINE, Valverde Morales, Claudia Maria, Schoffski, Patrick, Jones, Robin, Blay, Jean-Yves

المساهمون: Institut Català de la Salut, Schöffski P Department of General Medical Oncology, University Hospitals Leuven, Leuven. Laboratory of Experimental Oncology, KU Leuven, Leuven. Department of Oncology, Leuven Cancer Institute, Leuven, Belgium. Jones RL Sarcoma Unit, The Royal Marsden, London. The Institute of Cancer Research, London, UK. Agulnik M City of Hope, Department of Medical Oncology & Therapeutics Research, Duarte, USA. Blay JY Centre Léon Bérard, University Claude Bérard, Lyon, France. Chalmers A Huntsman Cancer Institute, University of Utah, Salt Lake City, USA. Italiano A Institut Bergonié, Bordeaux. Faculty of Medicine, University of Bordeaux, Bordeaux, France. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Decisió de grup, Tumors de parts toves - Tractament, Tumors de parts toves - Prognosi, Avaluació de resultats (Assistència sanitària), PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Adipose Tissue::Liposarcoma, Other subheadings::Other subheadings::/therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome::Progression-Free Survival, PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::psicología social::procesos de grupo::consenso, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido adiposo::liposarcoma, Otros calificadores::Otros calificadores::/terapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento::supervivencia libre de progresión

وصف الملف: application/pdf

Relation: ESMO Open;9(7); https://doi.org/10.1016/j.esmoop.2024.103487; Schöffski P, Jones RL, Agulnik M, Blay JY, Chalmers A, Italiano A, et al. Current unmet needs in locally advanced (unresectable) or metastatic dedifferentiated liposarcoma, the relevance of progression-free survival as clinical endpoint, and expectations for future clinical trial design: an international Delphi consensus report. ESMO Open. 2024 Jun 28;9(7):103487.; https://hdl.handle.net/11351/11669

الاتاحة: https://hdl.handle.net/11351/11669
https://doi.org/10.1016/j.esmoop.2024.103487

المؤلفون: Cortellini, Alessio, Mazzocca, Alessandro, Orlando, Sarah, Romandini, Davide, Valverde Morales, Claudia Maria, Eremiev, Simeón, Vincenzi, Bruno, Aguilar-Company, Juan, Ruiz- Camps, Isabel

المساهمون: Institut Català de la Salut, Vincenzi B, Cortellini A, Mazzocca A, Orlando S, Romandini D Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus BioMedico, Roma, Italy. Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Roma, Italy. Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Valverde Morales C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: COVID-19 (Malaltia) - Vacunació, COVID-19 (Malaltia) - Mortalitat, Tumors de parts toves - Quimioteràpia, DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination, AND EQUIPMENT::Investigative Techniques::Epidemiologic Methods::Data Collection::Vital Statistics::Morbidity, DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunoterapia activa::vacunación, DIAGNÓSTICOS Y TERAPÉUTICOS::técnicas de investigación::métodos epidemiológicos::recopilación de datos::estadísticas vitales::morbilidad, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de los tejidos blandos, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

Relation: Therapeutic Advances in Medical Oncology;16; https://doi.org/10.1177/17588359231225028; Vincenzi B, Cortellini A, Mazzocca A, Orlando S, Romandini D, Aguilar-Company J, et al. Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry. Ther Adv Med Oncol. 2024 Jan 18;16:1–11.; https://hdl.handle.net/11351/11606; 001087480202650

الاتاحة: https://hdl.handle.net/11351/11606
https://doi.org/10.1177/17588359231225028

المؤلفون: Mondaza Hernandez, Jose Lucinio, Sanchez-Bustos, Paloma, López Álvarez, María, Romagosa Pérez-Portabell, Cleofé, Valverde Morales, Claudia Maria, Moura, David, Peña-Chilet, Maria, Cordero Varela, Juan Antonio

المساهمون: Institut Català de la Salut, Moura DS Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IISFJD, UAM), Madrid, Spain. Department of Oncology in University Hospital Fundación Jiménez Díaz, Madrid, Spain. Mondaza-Hernandez JL Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IISFJD, UAM), Madrid, Spain. Sanchez-Bustos P, Cordero-Varela JA, Lopez-Alvarez M Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Seville, Spain. Peña-Chilet M Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Seville, Spain. Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, Seville, Spain. Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, Seville, Spain. Romagosa C Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tumors de parts toves - Tractament, Medicaments antineoplàstics - Ús terapèutic, Resistència als medicaments, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Muscle Tissue::Leiomyosarcoma, Other subheadings::Other subheadings::Other subheadings::/drug therapy, PHENOMENA AND PROCESSES::Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Neoplasm, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, Other subheadings::Other subheadings::/therapeutic use, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido muscular::leiomiosarcoma, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, FENÓMENOS Y PROCESOS::fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::resistencia a medicamentos::resistencia a los antineoplásicos, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, Otros calificadores::Otros calificadores::/uso terapéutico

وصف الملف: application/pdf

Relation: Cellular and Molecular Life Sciences;81(1); https://doi.org/10.1007/s00018-024-05250-y; Moura DS, Mondaza-Hernandez JL, Sanchez-Bustos P, Peña-Chilet M, Cordero-Varela JA, Lopez-Alvarez M, et al. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study. Cell Mol Life Sci. 2024 May 17;81(1):219.; https://hdl.handle.net/11351/11493

الاتاحة: https://hdl.handle.net/11351/11493
https://doi.org/10.1007/s00018-024-05250-y

المؤلفون: Kokkali, Stefania, Georgaki, Eleni, MANDRAKIS, GEORGIOS, Valverde Morales, Claudia Maria, Theocharis, Stamatios

المساهمون: Institut Català de la Salut, Kokkali S First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Oncology Unit, 2nd Department of Medicine, Medical School, Hippocratio General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece. Georgaki E Oncology Unit, 2nd Department of Medicine, Medical School, Hippocratio General Hospital of Athens, National and Kapodistrian University of Athens, Athens, Greece. Mandrakis G, Theocharis S First Department of Pathology, Medical School, National and Kapodistrian University of Athens, Athens, Greece. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tumors de parts toves - Aspectes genètics, Tumors de parts toves - Tractament, Medicina personalitzada, DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms, Other subheadings::Other subheadings::Other subheadings::/genetics, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Precision Medicine, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de los tejidos blandos, Otros calificadores::Otros calificadores::Otros calificadores::/genética, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::medicina de precisión

وصف الملف: application/pdf

Relation: Cells;12(22); https://doi.org/10.3390/cells12222632; Kokkali S, Georgaki E, Mandrakis G, Valverde C, Theocharis S. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas. Cells. 2023 Nov;12(22):2632.; https://hdl.handle.net/11351/10767; 001119933200001

الاتاحة: https://hdl.handle.net/11351/10767
https://doi.org/10.3390/cells12222632

المؤلفون: Razak, Albiruni Abdul, Rosenbaum, E., Jonczak, Emily, Hamacher, Rainer, Rutkowski, Piotr, Valverde Morales, Claudia Maria, HINDI, NADIA

المساهمون: Institut Català de la Salut, Hindi N Medical Oncology Department, Fundacion Jimenez Diaz University Hospital and Hospital General de Villalba, Madrid. Instituto de Investigación Sanitaria-Fundación Jimenez Díaz-UAM (IIS-FJD-UAM), Madrid, Spain. Razak A Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada. Rosenbaum E Memorial Sloan Kettering Cancer Center, New York. Jonczak E Department of Hematology Oncology, Miami University, Miami, USA. Hamacher R Medical Oncology Department, West German Cancer Center, University Hospital Essen, Essen, Germany. Rutkowsk P Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tumors de parts toves - Tractament, Immunoteràpia, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Muscle Tissue::Sarcoma, Alveolar Soft Part, Other subheadings::Other subheadings::Other subheadings::/drug therapy, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido muscular::sarcoma alveolar de partes blandas, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia

وصف الملف: application/pdf

Relation: ESMO Open;8(6); https://doi.org/10.1016/j.esmoop.2023.102045; Hindi N, Razak A, Rosembaum E, Jonczak E, Hamacher R, Rutkowski P, et al. Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry. ESMO Open. 2023 Dec;8(6):102045.; https://hdl.handle.net/11351/10835; 001130490900001

الاتاحة: https://hdl.handle.net/11351/10835
https://doi.org/10.1016/j.esmoop.2023.102045

المؤلفون: ALVAREZ, ROSA, MANZANO, ARANZAZU, Artigas Raventós, Vicente, Correa Generoso, Raquel, Cruz, Josefina, Valverde Morales, Claudia Maria, AGRA PUJOL, CAROLINA

المساهمون: Institut Català de la Salut, Álvarez Álvarez R Medical Oncology Department, Instituto de Investigacion Sanitaria Gregorio Marañon, Hospital Universitario Gregorio Marañon, Madrid, Spain. Manzano A Medical Oncology Department, Hospital Universitario Clínico San Carlos, Madrid, Spain. Agra Pujol C Pathology Department, Hospital Universitario Gregorio Marañon, Complutense University, Madrid, Spain. Artigas Raventós V Surgery Department, Hospital Universitario Sant Pau, Universidad Autònoma de Barcelona, Barcelona, Spain. Correa R Radiation Oncology Department, Hospital Virgen de la Victoria, Malaga, Spain. Cruz Jurado J Medical Oncology Department, Hospital Universitario Canarias, Santa Cruz de Tenerife, Spain. Valverde Morales C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tumors de parts toves - Tractament, Tumors de parts toves - Diagnòstic, Cèl·lules mare mesenquimàtiques, DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms, Other subheadings::Other subheadings::/diagnosis, ANATOMY::Cells::Connective Tissue Cells::Stromal Cells::Mesenchymal Stem Cells, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de los tejidos blandos, Otros calificadores::Otros calificadores::/diagnóstico, ANATOMÍA::células::células del tejido conectivo::células del estroma::células madre mesenquimatosas

وصف الملف: application/pdf

Relation: Cancers;15(12); https://doi.org/10.3390/cancers15123194; Álvarez Álvarez R, Manzano A, Agra Pujol C, Artigas Raventós V, Correa R, Cruz Jurado J, et al. Updated Review and Clinical Recommendations for the Diagnosis and Treatment of Patients with Retroperitoneal Sarcoma by the Spanish Sarcoma Research Group (GEIS). Cancers. 2023 Jun 15;15(12):3194.; https://hdl.handle.net/11351/9935

الاتاحة: https://hdl.handle.net/11351/9935
https://doi.org/10.3390/cancers15123194

المؤلفون: Bareche, Yacine, Abbas-Aghababazadeh, Farnoosh, Lo Giacco, Deborah, Martin Casado, Agatha, Saavedra Gadea, Omar, Berche, Roger, Mirallas, Oriol, Jimenez, Jose, Valverde Morales, Claudia Maria, Díez García, Marc, Hernando-Calvo, Alberto, Vila-Casadesús, Maria, Gonzalez Medina, Alberto, Brana, Irene, Vieito , Maria, fasani, roberta, Mancuso, Francesco Mattia, Saoudi Gonzalez, Nadia, Suárez, Cristina, Elez, Elena, Capdevila Castillon, Jaume, OAKNIN, ANA, Saura Manich, Cristina, Macarulla, Teresa, Carles, Joan, FELIP, ENRIQUETA, Nuciforo, Paolo, Seoane, Joan, Tabernero, Josep, GARRALDA, Elena, Vivancos, Ana, MUÑOZ COUSELO, EVA, Dienstmann, Rodrigo

المساهمون: Institut Català de la Salut, Hernando-Calvo A Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Vila-Casadesús M, Gonzalez-Medina A, Lo Giacco D, Martin A, Fasani R, Mancuso F, Berche R, Jimenez J, Dienstmann R, Nuciforo P, Seoane J, Vivancos A Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Bareche Y Institut du Cancer de Montréal, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Faculty of Pharmacy, Université de Montréal, Montréal, QC, Canada. Abbas-Aghababazadeh F Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. Saavedra O, Brana I, Vieito M, Mirallas O, Saoudi Gonzalez N, Valverde C, Muñoz-Couselo E, Suarez C, Diez M, Élez E, Capdevila J, Oaknin A, Saura C, Macarulla T, Carles Galceran J, Felip E, Tabernero J, Garralda E Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Càncer - Immunoteràpia, Càncer - Aspectes genètics, Fisiologia cel·lular, DISEASES::Neoplasms, Other subheadings::Other subheadings::Other subheadings::/genetics, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cellular Microenvironment::Tumor Microenvironment, ENFERMEDADES::neoplasias, Otros calificadores::Otros calificadores::Otros calificadores::/genética, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::microambiente celular::microambiente tumoral

وصف الملف: application/pdf

Relation: Med;4(10); https://doi.org/10.1016/j.medj.2023.07.006; Hernando-Calvo A, Vila-Casadesús M, Bareche Y, Gonzalez-Medina A, Abbas-Aghababazadeh F, Lo Giacco D, et al. A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials. Med. 2023 Oct 13;4(10):710-727.e5.; https://hdl.handle.net/11351/10525

الاتاحة: https://hdl.handle.net/11351/10525
https://doi.org/10.1016/j.medj.2023.07.006

المؤلفون: Pérez Fidalgo, José A, Ortega, Eugenia, Ponce Sebastia, Jordi, Redondo Sanchez, Andres, Sevilla, Isabel, Valverde Morales, Claudia Maria

المساهمون: Institut Català de la Salut, Pérez-Fidalgo JA Oncology and Hematology Department, INCLIVA Biomedical Research Institute, Hospital Clínico Universitario, CIBERONC Spain, Valencia, Spain. Ortega E Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. Ponce J Gynecology Department, Hospital Universitario de Bellvitge. IDIBELL. Universidad de Barcelona, Barcelona, Spain. Redondo A Medical Oncology Department, Hospital Universitario La PazIdiPAZ, Madrid, Spain. Sevilla I Clinical and Translational Research in Cancer/Instituto de Investigaciones Biomédicas de Málaga (IBIMA)/Hospitales Universitarios Regional and Virgen de la Victoria de Málaga, Málaga, Spain. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Úter - Càncer - Diagnòstic, Úter - Tumors - Diagnòstic, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Complex and Mixed::Sarcoma, Endometrial Stromal, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms, Other subheadings::Other subheadings::/diagnosis, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias complejas y mixtas::sarcoma del estroma endometrial, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas, Otros calificadores::Otros calificadores::/diagnóstico

وصف الملف: application/pdf

Relation: Therapeutic Advances in Medical Oncology;15; https://doi.org/10.1177/17588359231157645; Pérez-Fidalgo JA, Ortega E, Ponce J, Redondo A, Sevilla I, Valverde C, et al. Uterine sarcomas: clinical practice guidelines for diagnosis, treatment, and follow-up, by Spanish group for research on sarcomas (GEIS). Ther Adv Med Oncol. 2023 Mar 28;15:1–19.; https://hdl.handle.net/11351/9423; 000959665900001

الاتاحة: https://hdl.handle.net/11351/9423
https://doi.org/10.1177/17588359231157645

المؤلفون: Gounder, Mrinal M, Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M, Vincenzi, Bruno, Wagner, Andrew J, Chmielowski, Bartosz, Jones, Robin L, Riedel, Richard F, Stacchiotti, Silvia, Loggers, Elizabeth T, Ganjoo, Kristen N, Le Cesne, Axel, Italiano, Antoine, Garcia Del Muro, Xavier, Burgess, Melissa, Piperno-Neumann, Sophie, Ryan, Christopher, Mulcahy, Mary F, Forscher, Charles, Penel, Nicolas, Okuno, Scott, Elias, Anthony, Hartner, Lee, Philip, Tony, Alcindor, Thierry, Kasper, Bernd, Reichardt, Peter, Lapeire, Lore, Blay, Jean-Yves, Chevreau, Christine, Valverde Morales, Claudia Maria, Schwartz, Gary K, Chen, James L, Deshpande, Hari, Davis, Elizabeth J, Nicholas, Garth, Gröschel, Stefan, Hatcher, Helen, Duffaud, Florence, Herráez, Antonio Casado, Beveridge, Roberto Diaz, Badalamenti, Giuseppe, Eriksson, Mikael, Meyer, Christian, von Mehren, Margaret, Van Tine, Brian A, Götze, Katharina, Mazzeo, Filomena, Yakobson, Alexander, Zick, Aviad, Lee, Alexander, Gonzalez, Anna Estival, Napolitano, Andrea, Dickson, Mark A, Michel, Dayana, Meng, Changting, Li, Lingling, Liu, Jianjun, Ben-Shahar, Osnat, Van Domelen, Dane R, Walker, Christopher J, Chang, Hua, Landesman, Yosef, Shah, Jatin J, Shacham, Sharon, Kauffman, Michael G, Attia, Steven

المساهمون: Gounder, Mrinal M, Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Martin-Broto, Javier, Grignani, Giovanni, Schuetze, Scott M, Vincenzi, Bruno, Wagner, Andrew J, Chmielowski, Bartosz, Jones, Robin L, Riedel, Richard F, Stacchiotti, Silvia, Loggers, Elizabeth T, Ganjoo, Kristen N, Le Cesne, Axel, Italiano, Antoine, Garcia Del Muro, Xavier, Burgess, Melissa, Piperno-Neumann, Sophie, Ryan, Christopher, Mulcahy, Mary F, Forscher, Charle, Penel, Nicola, Okuno, Scott, Elias, Anthony, Hartner, Lee, Philip, Tony, Alcindor, Thierry, Kasper, Bernd, Reichardt, Peter, Lapeire, Lore, Blay, Jean-Yve, Chevreau, Christine, Valverde Morales, Claudia Maria, Schwartz, Gary K, Chen, James L, Deshpande, Hari, Davis, Elizabeth J, Nicholas, Garth, Gröschel, Stefan, Hatcher, Helen, Duffaud, Florence, Herráez, Antonio Casado, Beveridge, Roberto Diaz, Badalamenti, Giuseppe, Eriksson, Mikael, Meyer, Christian, von Mehren, Margaret, Van Tine, Brian A, Götze, Katharina, Mazzeo, Filomena, Yakobson, Alexander, Zick, Aviad, Lee, Alexander, Gonzalez, Anna Estival, Napolitano, Andrea, Dickson, Mark A, Michel, Dayana, Meng, Changting, Li, Lingling, Liu, Jianjun, Ben-Shahar, Osnat, Van Domelen, Dane R, Walker, Christopher J, Chang, Hua, Landesman, Yosef, Shah, Jatin J, Shacham, Sharon, Kauffman, Michael G, Attia, Steven

مصطلحات موضوعية: selinexor, dedifferentiated liposarcoma (DD-LPS)

Relation: info:eu-repo/semantics/altIdentifier/pmid/35394800; info:eu-repo/semantics/altIdentifier/wos/WOS:000855692200012; volume:40; issue:22; firstpage:2479; lastpage:2490; numberofpages:12; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/10447/547402

الاتاحة: http://hdl.handle.net/10447/547402
https://doi.org/10.1200/JCO.21.01829

المؤلفون: Gounder, Mrinal M., Razak, Albiruni Abdul, Somaiah, Neeta, Chawla, Sant, Marti Broto, Javier, Grignani, Giovanni, Schuetze, Scott M., Vincenzi, Bruno, Wagner, Andrew J., Chmielowski, Bartosz, Jones, Robin L., Riedel, Richard F., Stacchiotti, Silvia, Loggers, Elizabeth T., Ganjoo, Kristen N., Le Cesne, Axel, Italiano, Antoine, Garcia Del Muro, Xavier, Burgess, Melissa, Piperno Neumann, Sophie, Ryan, Christopher, Mulcahy, Mary F., Forscher, Charles, Penel, Nicolas, Okuno, Scott, Elias, Anthony, Hartner, Lee, Philip, Tony, Alcindor, Thierry, Kasper, Bernd, Reichardt, Peter, Lapeire, Lore, Blay, Jean Yves, Chevreau, Christine, Valverde Morales, Claudia Maria, Schwartz, Gary K., Chen, James L., Deshpande, Hari, Davis, Elizabeth J., Nicholas, Garth, Gröschel, Stefan, Hatcher, Helen, Duffaud, Florence, Herráez, Antonio Casado, Beveridge, Roberto Diaz, Badalamenti, Giuseppe, Eriksson, Mikael, Meyer, Christian, Von Mehren, Margaret, Van Tine, Brian A., Götze, Katharina, Mazzeo, Filomena, Yakobson, Alexander, Zick, Aviad, Lee, Alexander, Gonzalez, Anna Estival, Napolitano, Andrea, Dickson, Mark A., Michel, Dayana, Meng, Changting, Li, Lingling, Liu, Jianjun, Ben Shahar, Osnat, Van Domelen, Dane R., Walker, Christopher J., Chang, Hua, Landesman, Yosef, Shah, Jatin J., Shacham, Sharon, Kauffman, Michael G., Attia, Steven

المصدر: Articles publicats en revistes (Ciències Clíniques)

مصطلحات موضوعية: Sarcoma, Placebos, Placebos (Medicine)

وصف الملف: 15 p.; application/pdf

Relation: Reproducció del document publicat a: https://doi.org/10.1200/JCO.21.01829; Journal of Clinical Oncology, 2022, vol. 40, num. 22, p. 2479-2490; https://doi.org/10.1200/JCO.21.01829; http://hdl.handle.net/2445/190172; 732593

الاتاحة: http://hdl.handle.net/2445/190172

المؤلفون: Pantaleo, Maria Abbondanza, Heinrich, Michael C., Valverde Morales, Claudia Maria, Schöfski, Patrick, Grignani, Giovanni, Italiano, Antoine

المساهمون: Institut Català de la Salut, Pantaleo MA Division in Medical Oncology, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Heinrich MC Portland VA Health Care System and Oregon Health and Science University, Knight Cancer Institute, Portland, Oregon, USA. Italiano A Institut Bergonie, Bordeaux, France. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Schöffski P Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Laboratory of Experimental Oncology, KU Leuven, Leuven, Belgium. Grignani G Division of Medical Oncology, Candiolo Cancer Institute, TO, Italy, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Aparell digestiu - Càncer - Tractament, Avaluació de resultats (Assistència sanitària), DISEASES::Digestive System Diseases::Digestive System Neoplasms::Gastrointestinal Neoplasms::Digestive System Diseases::Gastrointestinal Stromal Tumors, Other subheadings::Other subheadings::Other subheadings::/drug therapy, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Prognosis::Treatment Outcome, ENFERMEDADES::enfermedades del sistema digestivo::neoplasias del sistema digestivo::neoplasias gastrointestinales::enfermedades del sistema digestivo::tumores del estroma gastrointestinal, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::pronóstico::resultado del tratamiento

وصف الملف: application/pdf

Relation: BMC Cancer;22; https://doi.org/10.1186/s12885-022-09610-4; Pantaleo MA, Heinrich MC, Italiano A, Valverde C, Schöffski P, Grignani G, et al. A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer. 2022 May 6;22:511.; https://hdl.handle.net/11351/8159; 000791786100010

الاتاحة: https://hdl.handle.net/11351/8159
https://doi.org/10.1186/s12885-022-09610-4

المؤلفون: Palmerini, Emanuela, Bollard, Julien, Aguiar Júnior, Samuel, Angel, Martín, B, Araya, Valverde Morales, Claudia Maria, Blay, Jean-Yves

المساهمون: Institut Català de la Salut, Blay JY, Bollard J Léon Bérard Center, Lyon Cedex, France. Palmerini E IRCCS Istituto Ortopedico Rizzoli, University of Bologna, Bologna, Italy. Aguiar S A. C. Camargo Cancer Center, São Paulo 01509-010, Brazil. Angel M Instituto Alexander Fleming, Buenos Aires, Argentina. Araya B Hospital Dr. R. A. Calderón Guardia, San José, Costa Rica. Valverde, CM Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ossos - Càncer - Diagnòstic, Sarcoma - Diagnòstic, DISEASES::Neoplasms::Neoplasms by Site::Bone Neoplasms, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma, Other subheadings::Other subheadings::/diagnosis, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias óseas, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma, Otros calificadores::Otros calificadores::/diagnóstico

وصف الملف: application/pdf

Relation: Critical Reviews in Oncology/Hematology;174; https://doi.org/10.1016/j.critrevonc.2022.103685; Blay JY, Palmerini E, Bollard J, Aguiar S, Angel M, Araya B, et al. SELNET clinical practice guidelines for bone sarcoma. Crit Rev Oncol Hematol. 2022 Jun;174:103685.; https://hdl.handle.net/11351/8127

الاتاحة: https://hdl.handle.net/11351/8127
https://doi.org/10.1016/j.critrevonc.2022.103685

المؤلفون: Redondo Sanchez, Andres, Valverde Morales, Claudia Maria, Morales, Jose Manuel, Lopez Pousa, Antonio, Martin-Broto, Javier, Moura, David

المساهمون: Institut Català de la Salut, Martin-Broto J Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain. Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Madrid, Spain. General de Villalba University Hospital, Madrid, Spain. Autonomous University of Madrid, Madrid, Spain. Redondo A Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. Moura DS Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Morales JM Radiology Department, Virgen del Rocio University Hospital, Sevilla, Spain. Lopez-Pousa A Medical Oncology Department, Sant Pau Hospital, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Teixit connectiu - Malalties - Tractament, Medicaments antineoplàstics - Ús terapèutic, Tumors de parts toves - Tractament, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Connective Tissue::Neoplasms, Fibrous Tissue::Fibroma::Fibromatosis, Aggressive, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, Other subheadings::Other subheadings::Other subheadings::/adverse effects, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido conjuntivo::neoplasias de tejido fibroso::fibroma::fibromatosis agresiva, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, Otros calificadores::Otros calificadores::Otros calificadores::/efectos adversos

وصف الملف: application/pdf

Relation: Nature Communications;13; https://doi.org/10.1038/s41467-022-33975-6; info:eu-repo/grantAgreement/EC/H2020/825806; Martin-Broto J, Redondo A, Moura DS, Valverde C, Morales JM, Lopez-Pousa A, et al. A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors. Nat Commun. 2022 Oct 21;13:6278.; https://hdl.handle.net/11351/8514; 000871124000023

الاتاحة: https://hdl.handle.net/11351/8514
https://doi.org/10.1038/s41467-022-33975-6

المؤلفون: D'Angelo, Sandra P, Araujo, Dejka M, Abdul Razak, Albiruni R, Agulnik, Mark, Attia, Steven, Blay, Jean-Yves, Carrasco Garcia, Irene, Charlson, John A, Choy, Edwin, Demetri, George D, Druta, Mihaela, Forcade, Edouard, Ganjoo, Kristen N, Glod, John, Keedy, Vicki L, Le Cesne, Axel, Liebner, David A, Moreno, Victor, Pollack, Seth M, Schuetze, Scott M, Schwartz, Gary K, Strauss, Sandra J, Tap, William D, Thistlethwaite, Fiona, Valverde Morales, Claudia Maria, Wagner, Michael J, Wilky, Breelyn A, McAlpine, Cheryl, Hudson, Laura, Navenot, Jean-Marc, Wang, Tianjiao, Bai, Jane, Rafail, Stavros, Wang, Ruoxi, Sun, Amy, Fernandes, Lilliam, Van Winkle, Erin, Elefant, Erica, Lunt, Colin, Norry, Elliot, Williams, Dennis, Biswas, Swethajit, Van Tine, Brian A

المصدر: The Lancet ; volume 403, issue 10435, page 1460-1471 ; ISSN 0140-6736

الاتاحة: http://dx.doi.org/10.1016/s0140-6736(24)00319-2
https://api.elsevier.com/content/article/PII:S0140673624003192?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0140673624003192?httpAccept=text/plain

المؤلفون: Martínez-Trufero, Javier, Sande-González, Luis Miguel de, Luna, Pablo, Martín-Broto, Javier, Alvarez, Rosa, Marquina, Gloria, Diaz-Beveridge, Roberto, Poveda, Andrés, Cano, Juana María, Cruz-Jurado, Josefina, López Pousa, Antonio, Salgado, María Angeles Vaz, Valverde-Morales, Claudia Maria., Sevilla, Isabel, Martínez-García, Jerónimo, Rubio-Casadevall, Jordi, de Juan Ferre, Ana, Carrasco, Juan Antonio, Moura, David S., Gurruchaga-Sotes, Ibon, Gutiérrez, Antonio

مصطلحات موضوعية: Trabectedin, Sarcoma, Growth modulation index, Prognostic score, L-sarcoma, GEISTRA

وصف الملف: application/pdf

Relation: Cancers; Vol. 13 Núm. 4 (february 2021), p. 1-15; https://ddd.uab.cat/record/272118; urn:10.3390/cancers13040792; urn:oai:ddd.uab.cat:272118; urn:scopus_id:85100802306; urn:pmid:33672857; urn:pmc-uid:7917652; urn:pmcid:PMC7917652; urn:oai:pubmedcentral.nih.gov:7917652

الاتاحة: https://ddd.uab.cat/record/272118

المؤلفون: Lostes Bardaji, M Julia, García Illescas, David, Valverde Morales, Claudia Maria, Serrano Garcia, César

المساهمون: Institut Català de la Salut, Lostes-Bardaji MJ, García-Illescas D, Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Serrano C Sarcoma Translational Research Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tracte gastrointestinal - Càncer - Tractament, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Digestive System Diseases::Digestive System Neoplasms::Gastrointestinal Neoplasms::Digestive System Diseases::Gastrointestinal Stromal Tumors, Other subheadings::Other subheadings::Other subheadings::/drug therapy, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents, Other subheadings::Other subheadings::/therapeutic use, ENFERMEDADES::enfermedades del sistema digestivo::neoplasias del sistema digestivo::neoplasias gastrointestinales::enfermedades del sistema digestivo::tumores del estroma gastrointestinal, Otros calificadores::Otros calificadores::Otros calificadores::/farmacoterapia, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos, Otros calificadores::Otros calificadores::/uso terapéutico

وصف الملف: application/pdf

Relation: Therapeutic Advances in Medical Oncology;13; https://doi.org/10.1177/1758835920986498; Lostes-Bardaji MJ, García-Illescas D, Valverde C, Serrano C. Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward. Ther Adv Med Oncol. 2021 Jan;13:1-12.; https://hdl.handle.net/11351/7143; 000610180700001

الاتاحة: https://hdl.handle.net/11351/7143
https://doi.org/10.1177/1758835920986498

المؤلفون: Valverde Morales, Claudia Maria

المساهمون: Romagosa Pérez-Portabella, Cleofé, Carles Galceran, Joan, Vargas Blasco, Víctor

مصطلحات موضوعية: Prescreening molecular, Molecular prscreening, Sarcoma, Plataformes genòmiques, Genomic platforms, Plataformas genómicas, Ciències de la Salut

وصف الملف: application/pdf

Relation: https://ddd.uab.cat/record/296498; urn:oai:ddd.uab.cat:296498; urn:oai:www.tdx.cat:10803/691591

الاتاحة: https://ddd.uab.cat/record/296498

المؤلفون: Grignani, Giovanni, Martínez-Trufero, Javier, Redondo Sanchez, Andres, Valverde Morales, Claudia Maria, Martin-Broto, Javier, Hindi, Nadia

المساهمون: Institut Català de la Salut, Martin-Broto J, Hindi N Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain. Institute of Biomedicine of Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Sevilla, Spain. Grignani G Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS - Str. Prov.le 142, km. 3,95 - Candiolo (TO) 10060, Candiolo, Italy. Martinez-Trufero J Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain. Redondo A Department of Medical Oncology, Hospital Universitario La Paz, Madrid, Spain. Valverde C Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Sarcoma - Tractament, Càncer - Immunoteràpia, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica

وصف الملف: application/pdf

Relation: Journal for ImmunoTherapy of Cancer;8(2); http://dx.doi.org/10.1136/jitc-2020-001561; Martin-Broto J, Hindi N, Grignani G, Martinez-Trufero J, Redondo A, Valverde C, et al. Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial. J Immunother Cancer. 2020;8(2):e001561.; https://hdl.handle.net/11351/6405; 000599997700001

الاتاحة: https://hdl.handle.net/11351/6405
https://doi.org/10.1136/jitc-2020-001561

المؤلفون: Jones, Robin L., Valverde Morales, Claudia Maria, Benson, Charlotte, Blay, Jean-Yves, Gelderblom, Hans, George, Suzanne

المساهمون: Institut Català de la Salut, Gelderblom H Leiden University Medical Center, Leiden, The Netherlands. Jones RL The Royal Marsden Hospital and Institute of Cancer Research, London, UK. George S Dana-Farber Cancer Institute Boston, Boston, MA, USA. Valverde Morales C Vall d’Hebron Hospital Universitari, Barcelona, Spain. Benson C The Royal Marsden Hospital, London, UK. Blay JY Centre Léon Bérard, Lyon, France. Unicancer, Paris, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Tub digestiu - Càncer - Quimioteràpia, DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Connective Tissue::Gastrointestinal Stromal Tumors, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols, Other subheadings::Other subheadings::/therapeutic use, ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido conjuntivo::tumores del estroma gastrointestinal, TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada, Otros calificadores::Otros calificadores::/uso terapéutico

وصف الملف: application/pdf

Relation: British Journal of Cancer;122(8); https://doi.org/10.1038/s41416-020-0769-y; Gelderblom H, Jones RL, George S, Valverde Morales C, Benson C, Blay JY, et al. Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study. Br J Cancer. 2020 Apr 14;122(8):1158–65.; https://hdl.handle.net/11351/6439; 000518499500001

الاتاحة: https://hdl.handle.net/11351/6439
https://doi.org/10.1038/s41416-020-0769-y